US 11400123
Combination product for prophylaxis and treatment of irritable bowel syndrome
granted A61KA61K35/745A61K35/747
Quick answer
US patent 11400123 (Combination product for prophylaxis and treatment of irritable bowel syndrome) held by PrecisionBiotics Group Limited expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PrecisionBiotics Group Limited
- Grant date
- Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K35/745, A61K35/747, A61K45/06, A61K9/19